# Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

> **NCT05551104** · PHASE3 · RECRUITING · sponsor: **Loma Linda University** · enrollment: 500 (estimated)

## Conditions studied

- Postpartum Complication
- Maternal Hypertension
- High Blood Pressure

## Interventions

- **DRUG:** Oral Nifedipine
- **DRUG:** Oral Labetalol

## Key facts

- **NCT ID:** NCT05551104
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-08
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551104, "Safest Choice of Antihypertensive Regimen for Postpartum Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05551104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*